Ap. Jillella et Cl. Lutcher, REINSTITUTING WARFARIN IN PATIENTS WHO DEVELOP WARFARIN SKIN NECROSIS, American journal of hematology, 52(2), 1996, pp. 117-119
Skin necrosis is a rare but serious complication of oral anticoagulati
on with coumarin derivatives. Frequently, the necrosis can be extensiv
e and may result in major morbidity and mortality. The majority of the
se patients require prolonged anticoagulation for life-threatening con
ditions such as deep venous thrombosis and pulmonary embolism. Resumin
g oral anticoagulants in the face of skin necrosis is a difficult deci
sion for both the patient and the physician. Because long-term heparin
therapy is inconvenient and is associated with significant side effec
ts, we reviewed the literature to find alternative treatment strategie
s. A Medline search was done, and all papers published in English sinc
e 1967 were reviewed. Of 58 cases with skin necrosis attributed to ora
l anticoagulants, oral anticoagulation was resumed in 7 patients with
no resulting adverse effects. Warfarin is the most widely used coumari
n derivative in the United States. Based on our review, we make recomm
endations for resuming warfarin in patients who have developed skin ne
crosis when the clinical condition absolutely requires prolonged antic
oagulation. (C) 1996 Wiley-Liss, Inc.